当前位置: 首页 >> 检索结果
共有 7000 条符合本次的查询结果, 用时 5.9342842 秒

6081. Liver involvement in adult-onset Still's disease: our experience in a third level liver unit and review of the literature.

作者: Michele Roma.;Silvia Bonetto.;Ilaria Giovo.;Daniela Campion.;Felice Rizzi.;Clara L Peroni.;Giorgio M Saracco.;Carlo Alessandria.
来源: Minerva Gastroenterol (Torino). 2023年69卷4期537-545页
Adult-onset Still's Disease (AOSD) is a systemic inflammatory condition, mainly characterized by high spiking fevers, leukocytosis, skin rash, arthralgia and myalgia. Liver involvement is a frequent feature, usually presenting with hepatomegaly and mild liver enzymes abnormalities, which usually normalize after treatment with anti-inflammatory or immunomodulatory drugs given for AOSD. Although uncommon, the onset of severe acute hepatitis and even of life-threatening liver failure is possible and requires a prompt diagnosis and an aggressive therapy and, in some cases, an emergency liver transplantation. The differential diagnosis of the cause of the liver injury can be very challenging in these patients. We reviewed the charts of all consecutive patients admitted for acute hepatitis, between January 2019 and December 2019, to the unit of Gastroenterology and Hepatology, Molinette Hospital, Turin, Italy, searching for episodes AOSD-related. In this period, 21 cases of acute hepatitis were recorded with one among them diagnosed as due to AOSD. The incidence was 5% (1/21). This patient was a woman with a recent diagnosis of AOSD who developed a severe acute seronegative biopsy-proven autoimmune hepatitis. She was successfully treated with high-dose methylprednisolone, with a full and stable recovery from the liver injury. We discussED the incidence, etiology, pathophysiology, diagnosis, and standard of treatment in the clinical management of AOSD with a special attention and a systematic review on the available therapies for severe liver involvement associated with AOSD.

6082. Pembrolizumab-induced acute diverticulitis.

作者: Antonio Tursi.
来源: Minerva Gastroenterol (Torino). 2023年69卷2期317-318页

6083. Re-FIT-ting Colorectal Cancer Screening During and Beyond COVID.

作者: Catherine Dubé.
来源: Gastroenterology. 2021年161卷2期418-420页

6084. The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis.

作者: Amir-Houshang Omidvari.;William D Hazelton.;Brianna N Lauren.;Steffie K Naber.;Minyi Lee.;Ayman Ali.;Claudia Seguin.;Chun Yin Kong.;Ellen Richmond.;Joel H Rubenstein.;Georg E Luebeck.;John M Inadomi.;Chin Hur.;Iris Lansdorp-Vogelaar.
来源: Gastroenterology. 2021年161卷2期487-494.e4页
Current guidelines recommend surveillance for patients with nondysplastic Barrett's esophagus (NDBE) but do not include a recommended age for discontinuing surveillance. This study aimed to determine the optimal age for last surveillance of NDBE patients stratified by sex and level of comorbidity.

6085. Impact of second forward-view examination on adenoma detection rate during unsedated colonoscopy: a randomized controlled trial.

作者: Keshu Shan.;Hongpeng Lu.;Zhixin Zhang.;Jiarong Xie.;Lu Xu.;Weihong Wang.;Chunjiu Hu.;Lei Xu.
来源: BMC Gastroenterol. 2021年21卷1期213页
Colorectal cancer on the right side of the colon has been suggested to be harder to detect by colonoscopy. The aim of this study was to evaluate whether a second forward-view examination of the right side of the colon could increase the adenoma detection rate (ADR) and/or polyp detection rate (PDR).

6086. Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency.

作者: Kota Uetsuki.;Hiroki Kawashima.;Eizaburo Ohno.;Takuya Ishikawa.;Tadashi Iida.;Kenta Yamamoto.;Kazuhiro Furukawa.;Masanao Nakamura.;Takashi Honda.;Masatoshi Ishigami.;Yoshiki Hirooka.;Mitsuhiro Fujishiro.
来源: BMC Gastroenterol. 2021年21卷1期211页
Pancreatic exocrine insufficiency (PEI) is associated with the outcome of pancreatic disease. However, there is no method for assessing PEI that can be used noninvasively and easily for outpatient. It has been reported that changes in intestinal bacteria caused by PEI may increase breath hydrogen concentration (BHC) levels during glucose or lactose loading. We have evaluated the usefulness of fasting breath hydrogen concentration (FBHC) measurement without glucose loading for the evaluation of PEI.

6087. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.

作者: Yu-Ling Chen.;Hao Li.;Shu Li.;Zhou Xu.;Shen Tian.;Juan Wu.;Xin-Yu Liang.;Xin Li.;Zi-Li Liu.;Jun Xiao.;Jia-Ying Wei.;Chen-Yu Ma.;Kai-Nan Wu.;Liang Ran.;Ling-Quan Kong.
来源: BMC Gastroenterol. 2021年21卷1期212页
Metabolic associated fatty liver disease (MAFLD) is a new definition for liver disease associated with known metabolic dysfunction. Based on new diagnostic criteria, we aimed to investigate its prevalence and risk factors in Chinese population.

6088. Discovery and validation of novel protein markers in mucosa of portal hypertensive gastropathy.

作者: Ying Zhu.;Wen Xu.;Wei Hu.;Fang Wang.;Yan Zhou.;Jianguo Xu.;Wei Gong.
来源: BMC Gastroenterol. 2021年21卷1期214页
Portal hypertension induced esophageal and gastric variceal bleeding is the main cause of death among patients of decompensated liver cirrhosis. Therefore, a standardized, biomarker-based test, to make an early-stage non-invasive risk assessment of portal hypertension, is highly desirable. However, no fit-for-purpose biomarkers have yet been identified.

6089. Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease.

作者: Qianqian Ma.;Xianhua Liao.;Congxiang Shao.;Yansong Lin.;Tingfeng Wu.;Yanhong Sun.;Shi-Ting Feng.;Junzhao Ye.;Bihui Zhong.
来源: BMC Gastroenterol. 2021年21卷1期215页
The normalization of liver biochemical parameters usually reflects the histological response to treatment for nonalcoholic fatty liver disease (NAFLD). Researchers have not clearly determined whether different liver enzymes exhibit various metabolic changes during the follow-up period in patients with NAFLD.

6090. Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient.

作者: Gianni Testino.;Rinaldo Pellicano.
来源: Minerva Gastroenterol (Torino). 2021年67卷3期283-288页
World Gastroenterology Organization define acute on chronic liver failure (ACLF) a syndrome in patients with chronic liver disease with or without previously diagnosed cirrhosis, characterized by acute hepatic decompensation resulting in liver failure and one or more extrahepatic organ failures, associated with increased mortality up to three months. A-56-year-old gentleman with alcohol related liver cirrhosis (ARLC) and history of variceal bleeding with insertion of transjugular intrahepatic porto-systemic stent shunt presented with two days history of fever, dry cough and worsening of the sensory. The severe acute respiratory coronavirus-2 (SARS-CoV-2) nasopharingeal C-reactive protein test was positive. X-ray showed multiple patchy ground glass opacities in both lungs. Despite the therapy, the clinical and laboratory picture deteriorated rapidly. The patient succumbed on day 14 with multi-organ-failure. SARS-Cov-2 infection can overlap with pre-existing chronic liver disease or induce liver damage directly or indirectly. From the data of the literature and from what is inferred from the case report it clearly emerges that alcohol related liver disease (ALD) patients are particularly vulnerable to SARS-Cov-2 infection. Thereafter, some considerations can be deduced from the analysis of the case report. In subjects with pre-existing cirrhosis hepatologists should play more attention to hepatic injury and monitor risk of hepatic failure caused by coronavirus disease 2019 (COVID-19). It is appropriate to promptly define the alcoholic etiology and investigate whether the patient is actively consuming. In fact, withdrawal symptoms may be present, and the prognosis of these patients is also worse. Physicians should be alerted to the possibility of the development of ACLF in this population, hepatotoxic drugs should be avoided, it is recommended to use of hepatoprotective therapy to mitigate the negative impact of COVID-19, and it is mandatory to administer anti COVID-19 vaccine to patients with alcohol related liver cirrhosis.

6091. Substances use disorders and liver injury: a concise review.

作者: Gianni Testino.;Patrizia Balbinot.;Rinaldo Pellicano.
来源: Minerva Gastroenterol (Torino). 2022年68卷3期269-276页
Substance use disorders (SUDs) are often associated with alcohol use disorders (AUDs) and psychiatric comorbidities. In addition, they are often subjected to polytherapy. For these reasons SUDs patients are at greater risk of developing liver disease. In this concise review, liver damage from amphetamines, cannabinoids, cocaine and opioids is analyzed and the need to identify a possible associated alcohol use disorder is also suggested. Early identification of liver fibrosis is required in SUDs patients. Fibrosis is the most significant predictor of both prognosis and long-term survival. Its identification helps to promote the abstention from substances and alcohol. Active use of heroin, cocaine and synthetic substances is an absolute contraindication for liver transplantation. In cases of remission and adherence to a significant care path, the patient is re-evaluated. An addiction specialist should be present within the transplant team. If this is not present, a close collaboration with an addiction unit is mandatory.

6092. Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C.

作者: Grazia Pennisi.;Federica Spatola.;Lorenza DI Marco.;Vincenzo DI Martino.;Vito DI Marco.
来源: Minerva Gastroenterol (Torino). 2021年67卷3期254-263页
In the last years the Hepatitis C virus (HCV) infection was a relevant public health problem due to the large number of affected people worldwide and the impact on hepatic and extrahepatic complications. The availability of direct-acting antivirals (DAAs) and the very high rate of sustained virological response (SVR) after treatment has radically changed the course of HCV chronic infection.

6093. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet is associated with increased risk of uninvestigated chronic dyspepsia and its symptoms in adults.

作者: Payman Adibi.;Ahmad Esmaillzadeh.;Hamed Daghaghzadeh.;Ammar Hassanzadeh Keshteli.;Awat Feizi.;Fahimeh Haghighatdoost.;Mohammad Jafari.
来源: Minerva Gastroenterol (Torino). 2023年69卷3期335-343页
Assessing the potential effects of a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) diet on functional gastrointestinal symptoms, particularly upper gastrointestinal symptoms, is not clearly understood. The current study aimed to explore the association of a diet low in FODMAPs with uninvestigated chronic dyspepsia (UCD) and functional dyspeptic symptoms in a large population of Iranian adults.

6094. Glucocorticoids and Androgens Protect From Gastric Metaplasia by Suppressing Group 2 Innate Lymphoid Cell Activation.

作者: Jonathan T Busada.;Kylie N Peterson.;Stuti Khadka.;Xiaojiang Xu.;Robert H Oakley.;Donald N Cook.;John A Cidlowski.
来源: Gastroenterology. 2021年161卷2期637-652.e4页
The immune compartment is critical for maintaining tissue homeostasis. A weak immune response increases susceptibility to infection, but immune hyperactivation causes tissue damage, and chronic inflammation may lead to cancer development. In the stomach, inflammation damages the gastric glands and drives the development of potentially preneoplastic metaplasia. Glucocorticoids are potent anti-inflammatory steroid hormones that are required to suppress gastric inflammation and metaplasia. However, these hormones function differently in males and females. Here, we investigate the impact of sex on the regulation of gastric inflammation.

6095. Primary squamous cell carcinoma of the pancreas with a large pseudocyst of the pancreas as the first manifestation: a rare case report and literature review.

作者: Xia Qiu.;Yajie Meng.;Meiqin Lu.;Chuan Tian.;Min Wang.;Junwen Zhang.
来源: BMC Gastroenterol. 2021年21卷1期208页
Primary squamous cell carcinoma (SCC) of the pancreas with pseudocysts, especially diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), is extremely rare.

6096. Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.

作者: Hsu-Heng Yen.;Pei-Yuan Su.;I-L Ing Liu.;Ya-Huei Zeng.;Siou-Ping Huang.;Yu-Chun Hsu.;Po-Ke Hsu.;Yang-Yuan Chen.
来源: BMC Gastroenterol. 2021年21卷1期209页
Hepatitis C virus (HCV) is one of the major causes of chronic liver disease, cirrhosis, and liver cancer. Most of the infected people have no clinical symptoms. The current strategy for HCV elimination includes test and treatment. In this study, we aimed to evaluate the campaign for retrieving patients who were lost to follow-up, for subsequent re-evaluation.

6097. Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.

作者: Yosuke Shimodaira.;So Takahashi.;Katsunori Iijima.
来源: BMC Gastroenterol. 2021年21卷1期207页
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell death protein-1, and anti-cytotoxic T-lymphocyte-associated protein antibodies, affect intestinal immune homeostasis and cause intestinal inflammation. Development of enteritis due to dupilumab (an anti-IL-4Ralpha monoclonal antibody) therapy is not yet reported in the literature.

6098. Systemic lupus erythematosus complicated by Crohn's disease with rectovaginal fistula.

作者: Heng Yeh.;Ren-Chin Wu.;Wen-Sy Tsai.;Chia-Jung Kuo.;Ming-Yao Su.;Cheng-Tang Chiu.;Puo-Hsien Le.
来源: BMC Gastroenterol. 2021年21卷1期206页
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease, and few cases combine with Crohn's disease. We present the first SLE patient concurrent with Crohn's disease and rectovaginal fistula. She was successfully treated with vedolizumab and surgical intervention. Besides, she also had a rare opportunistic infection, cryptococcal pneumonia, in previous adalimumab treatment course.

6099. Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study.

作者: Chuandong Sun.;Zhu Li.;Zheng Shi.;Guichen Li.
来源: BMC Gastroenterol. 2021年21卷1期210页
Efficacy of pancreatic enzyme inhibitors in acute pancreatitis (AP) is unclear in China.

6100. Refractory Constipation in a 53-Year-Old Man.

作者: Hiroaki Nakagawa.;Yasushi Miyata.
来源: Gastroenterology. 2021年161卷2期429-430页
共有 7000 条符合本次的查询结果, 用时 5.9342842 秒